Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity.
about
The complex cascade of cellular events governing inflammasome activation and IL-1β processing in response to inhaled particlesNLRP3 inflammasome: activation and regulation in age-related macular degenerationUbiquitin in the immune systemOf inflammasomes and pathogens--sensing of microbes by the inflammasomeInflammasomes: mechanism of action, role in disease, and therapeuticsAn Update on PYRIN Domain-Containing Pattern Recognition Receptors: From Immunity to PathologyMechanisms of inflammasome activation: recent advances and novel insightsThe ubiquitin system: a critical regulator of innate immunity and pathogen-host interactionsDeubiquitinases: Novel Therapeutic Targets in Immune Surveillance?The Roles of Autophagy and the Inflammasome during Environmental Stress-Triggered Skin InflammationUbiquitin in Influenza Virus Entry and Innate ImmunityModulation of the Inflammasome Signaling Pathway by Enteropathogenic and Enterohemorrhagic Escherichia coliInternational Union of Basic and Clinical Pharmacology. XCVI. Pattern recognition receptors in health and diseaseInitiation and perpetuation of NLRP3 inflammasome activation and assemblyLinear ubiquitination in immunityA BRISC-SHMT complex deubiquitinates IFNAR1 and regulates interferon responsesRegulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung DiseaseThe PYRIN Domain-only Protein POP1 Inhibits Inflammasome Assembly and Ameliorates Inflammatory DiseaseActivity-Based Proteomic Profiling of Deubiquitinating Enzymes in Salmonella-Infected Macrophages Leads to Identification of Putative Function of UCH-L5 in Inflammasome RegulationEnteropathogenic Escherichia coli Uses NleA to Inhibit NLRP3 Inflammasome ActivationUsp12 stabilizes the T-cell receptor complex at the cell surface during signalingNLRP3 Inflammasome in Neurological Diseases, from Functions to TherapiesActivation and regulation of the inflammasomesThe linear ubiquitin assembly complex (LUBAC) is essential for NLRP3 inflammasome activation.The NLRP3 inflammasome activation in human or mouse cells, sensitivity causes puzzle.Targeting the deubiquitinase STAMBP inhibits NALP7 inflammasome activity.Mechanism of NLRP3 inflammasome activation[The inflammasomes: platforms of innate immunity].Caspase-1: an integral regulator of innate immunity.Neutrophils counteract autophagy-mediated anti-inflammatory mechanisms in alveolar macrophage: role in posthemorrhagic shock acute lung inflammation[Caspase-1 regulates autoinflammation in rheumatic diseases].G Protein signaling modulator-3 inhibits the inflammasome activity of NLRP3Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomideNedd8 regulates inflammasome-dependent caspase-1 activation.IKKα negatively regulates ASC-dependent inflammasome activation.3,4-methylenedioxy-β-nitrostyrene inhibits NLRP3 inflammasome activation by blocking assembly of the inflammasome.AIM2 and NLRC4 inflammasomes contribute with ASC to acute brain injury independently of NLRP3.K+ efflux agonists induce NLRP3 inflammasome activation independently of Ca2+ signaling.Regulation of inflammasome activation.Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?
P2860
Q26741584-9915657E-057E-412D-8484-C0A3FD2DC0A3Q26995315-5CB396A7-ED06-4F69-AB77-897444E1F8E6Q26998711-797B9F5E-AD02-447C-A2E9-3B2C39613121Q27000785-F9729F3B-D11B-44F1-92B9-5715056E0982Q27001186-3AE3AF53-8B78-4051-BF2C-DBD37C114FFAQ27004333-2D0AE4AE-AD20-4EEC-9216-7B48A92661A3Q27005760-F3779135-FA46-4924-B3AA-E8350E054B5EQ28067104-0D6C0D2A-101A-4930-9161-95108561959AQ28069021-6198EB2C-68DA-458F-87C5-8088D089BAAFQ28073646-6F462B72-74A5-4BAF-AB50-D843E0FC1359Q28077694-704A4041-25E1-4420-9E03-D0DB777A83AEQ28079739-0AF0916C-BC34-4548-ABBD-93CC84987D21Q28081406-550B04FB-10E8-4477-87E0-75735F42CB92Q28082177-7D7F8B41-F90E-4004-AE26-69683530F537Q28082899-6DDA03A4-70D5-47D1-9783-49286C5902C3Q28118033-1EB6133A-4E54-43ED-9B54-2BC6E2F069E3Q28391348-F35DEA91-8003-4742-8802-C63C1938FCDCQ28395210-B7C08FA9-DDC0-4678-9910-B57C79E35567Q28547188-0ED0361D-59F8-4028-B0A6-8ADA0B673D1BQ28547711-90F13F2D-75D1-4128-A0E9-F9A0C41297FBQ28941247-915025FF-0B63-4278-B01A-F40130D217F3Q29248417-928AE11F-11F0-4984-AAFC-EE026DE75E27Q29615664-6B205105-FE57-46A3-8275-0B305B4D77DDQ30582098-5EC2C4D8-58CC-4AA5-9153-2698D189CB90Q33356058-9A6E2E3C-29EA-43D0-A8F9-161B12CD568CQ33705575-39C3C8D4-2E72-449B-9B33-B3DCF2648883Q33817836-DF11A814-3146-4D23-A36A-1CC6AA6C7247Q34039132-8FE1C76D-88CC-49A0-9A93-839AEAEED38DQ34044187-6F12D244-9D31-43B4-A77F-CC2F77DF0822Q34364798-781B680C-009A-415F-9FE7-F75826FF9F6CQ34520488-4BCE5D05-4754-4A21-B795-5A91DB15408EQ34580284-3356F9A4-98A1-4D43-9597-5863C4250D88Q34786598-CAFF442F-3EDD-46B8-B2BE-7E25A82561D3Q34846646-A26D8894-C9B5-4B13-8317-BBC196E9785EQ34982165-47CE7D30-7CB4-499D-ACEA-1C60FF64636DQ35050189-A3120020-C819-425F-9FC7-A8FB4CDEA098Q35279584-ED15A65E-034B-413D-9190-EEB21CDA0981Q35328973-CC1BC53F-682C-4919-88E8-C89A6C2ACD49Q35456425-F4FA0C34-8A0F-478C-8007-541E7137F80DQ35486035-D238C24E-D64B-4486-B12B-7E09EA6E19E0
P2860
Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity.
@en
Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity.
@nl
type
label
Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity.
@en
Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity.
@nl
prefLabel
Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity.
@en
Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity.
@nl
P2093
P1433
P1476
Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity
@en
P2093
Helin Vakifahmetoglu-Norberg
Junying Yuan
Mi-Sung Kim
P304
P356
10.1016/J.MOLCEL.2012.11.009
P50
P577
2012-12-13T00:00:00Z